Journal of Immunology Research / 2012 / Article / Tab 2

Research Article

Macrophage Migration Inhibitory Factor in Fetoplacental Tissues from Preeclamptic Pregnancies with or without Fetal Growth Restriction

Table 2

Concentration of MIF in normal and pathological samples.

Number of patientsPlacental tissue (pg/mg)Fetal membranes (pg/mg)Umbilical cord tissue (pg/mg) valuea

Controls8163,8* (112,4)87,7 (88,1)72,3* (46,4) *0,034
All PE20119,5 (80,3)112,8 (105,5)85,6 (58,2)n.s.
 PE-AGA10142,8* (94,6)162,2° (116,7)60,9*° (48,4) *0,006; °0,005
 PE-FGR1093,7 (51,9)58,0° (54,5)107,5° (58,5) °0,038

PE: preeclampsia.
PE-AGA: preeclamptic pregnancies with appropriate-for-gestational-age newborns.
PE-FGR: preeclamptic pregnancies with fetal growth restriction.
n.s.: not significant.
a values were calculated by ANOVA test, followed by Tamhane test for pair-wise comparison.
*Comparison between placental and umbilical cord MIF concentrations.
°Comparison between fetal membranes and umbilical cord MIF concentrations.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.